Abstract:OBJECTIVE:To investigate an inhibitive effect of the chitosan nanoparticles with the proliferation cell nuclear antigen (PCNA)-antisense oligo deoxy nucleotides (ASODN) on the intimal cell proliferation after the vein grafting. METHODS:Fifty-four male SD rats, weighing 450-600 g, were randomly divided in the experimental group and the control group of 27 rats each. In the experimental group, the chitosan nanoparticles with PCNA-ASODN were infused into the anastomosis segment of the right jugular artery and vein; then, the anastomosis segment was transplanted to the jugular artery on the same side. The rats in the control group were infused with normal saline by the same procedures. There were 24 rats in each group which used to experiment. The hemodynamic data were obtained from the Doppler ultrasound examinations at 1, 2, 3 and 4 weeks. The specimens were taken. Immunohistochemistry, Western-blot, and blood-vessel-wall histopathology were performed at the different week points. RESULTS:There was no significant difference in the thrombogenesis rate between the experimental group and the control group (3/27 vs. 3/27, P > 0.05). During the 4-week observation, PCNA Western-blot showed that the PCNA level was lower in the grafted vein and the anastomosis segment in the experimental group than in the control group. The indexes of the PCNA-postive proliferating cells in the intimal area (0.13% +/- 0.11%, 0.79% +/- 0.28%, 0.45% +/- 0.29%, 0.43% +/- 0.25%) and the medial area (1.90% +/- 0.84%, 2.11% +/- 0.98%, 2.48% +/- 0.77%, 2.17% +/- 0.36%) were significantly decreased at 1, 2, 3 and 4 weeks in the experimental group when compared with those in the control group (P < 0.05). The lumen areas in the grafted vein (88.71 +/- 16.96, 95.98 +/- 21.44, 88.48 +/- 32.81, 97.86 +/- 34. 11 microm2) and the anastomosis segment (41.49 +/- 3.34, 45.15 +/- 11.65, 46.27 +/- 8.90, 51.62 +/- 8.85 microm2) were significantly greater in the experimental group than in the control group (P < 0.05). The ratios of the initmal area to the medial area in the grafted vein (22.73% +/- 3.11%, 32.40% +/- 4.55%, 45.14% +/- 3.19%, 45.70% +/- 5.01%) and the anastomsis segment (41.49% +/- 3.34%, 45.15% +/- 11.65%, 46.27% +/- 8.90%, 51.62% +/- 8.85%) were significantly smaller in the experimental group than in the control group (P < 0.05). The maximum velocities (Vmax) of the blood flow in the grafted vein and the anastomsis segment were almost the same in the two groups at 1 week, but had different changes at the next 3 week-points. In the control group, the Vmax of the blood flow gradually increased and at 3 weeks it reached the peak point; however, at 4 weeks it decreased. In the experimental group, the Vmax of the blood flow gradually decreased, and at 3 weeks it decreased to the lowest point; however, at 4 weeks it increased. So, at 4 weeks the Vmax of the blood flow in the grafted vein and the anastomsis segment was almost the same in the two groups. There was no significant difference in the Vmax of the blood flow between the two groups (P > 0.05), but in the same group there was a significant difference at the different time points. CONCLUSION:The chitosan nanoparticles with PCNA-ASODN can effectively inhibit the intimal cell proliferation after the grafting of the blood vessel, so that the neointimal thickening can be prevented.

Short-term Effects of Double-Layer Autologous Vein Graft on Restraint of Excessive Distension and Alleviation of Neointimal Hyperplasia in a Porcine Saphenous Vein Graft Model

Wall Shear and Circumferential Stress Changes in A Porcine Double-Layer Vein Graft

Experimental Study of Saphenous Vein Grafts Restenosis Prevention by External Stents

A Macro-porosity, Nonrestrictive External Stent Inhibits Rabbit Vein Graft Neointima Thickening

Characterization of the Inhibition of Vein Graft Intimal Hyperplasia by a Biodegradable Vascular Stent

Can Endothelial Seeding Enhance Patency and Inhibit Neointimal Hyperplasia? Experimental Studies and Clinical Trial of Endothelial Seeded Venous Prostheses

Effects of the Different-Sized External Stents on Vein Graft Intimal Hyperplasia and Inflammation

Inhibitory Effect of Polydioxanone Suture External Stent on the Vein Graft Neointima Thickening and the Possible Mechanism

Influence of Ischemia Before Vein Grafting on Early Hyperplasia of the Graft and the Dynamic Changes of the Intima after Grafting.

Experimental study of arterialized vein graft remodeling

Effect of Inhibiting Perivascular Adhesion on Intimal Hyperplasia of the Vein Grafts in Rabbits

Periadventitial human stem cell treatment reduces vein graft intimal thickening in pig vein-into-artery interposition grafts

Effects of SDF-1α on vein graft restenosis in rats

[Inhibition of Intimal Proliferation after Vein Grafting by Chitosan Nanoparticle with Proliferation Cell Nuclear Antigen-Antisense Oligo Deoxy Nucleotides].

Autologous vein supported with a biodegradable prosthesis for arterial grafting

Biomechanics and Mechanobiology of Saphenous Vein Grafts

Supporting, Microporous, Elastomeric, Degradable Prostheses to Improve the Arterialization of Autologous Vein Grafts

A Novel External Stent Prepared by Electospinning Reduces Neointimal Hyperplasia of Vein Grafts

Morphologic and Molecular Changes of Autologous Artery Graft Interposed to Vein

Constitution of Vein Graft Stenosis Model

Empirical Study of Transfecting Early Growth Response Gene‐1 DNA Enzyme to Prevent Intimal Hyperlasia of Autogenous Vein Graft in Rats